IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $476,306,000 | -20.5% | 10,594 | 0.0% | 0.01% | -28.6% |
| Q4 2020 | $598,985,000 | +19.2% | 10,594 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $502,685,000 | -19.5% | 10,594 | 0.0% | 0.01% | -22.2% |
| Q2 2020 | $624,622,000 | +24.7% | 10,594 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $500,884,000 | -21.7% | 10,594 | 0.0% | 0.01% | +12.5% |
| Q4 2019 | $639,984,000 | +0.8% | 10,594 | 0.0% | 0.01% | -11.1% |
| Q3 2019 | $634,687,000 | -6.8% | 10,594 | 0.0% | 0.01% | -10.0% |
| Q2 2019 | $680,876,000 | +4.9% | 10,594 | -40.2% | 0.01% | +42.9% |
| Q3 2016 | $649,114,000 | -64.9% | 17,716 | -80.7% | 0.01% | -65.0% |
| Q2 2016 | $1,847,955,000 | +978.7% | 91,893 | +2072.4% | 0.02% | +900.0% |
| Q1 2016 | $171,315,000 | -34.6% | 4,230 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $261,964,000 | – | 4,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |